Min Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Min Liu has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- De-Gang Mo
School of Medicine, Qingdao University, Qingdao, China
2 shared publications De-Gang Mo
Department of Cardiology, Qingdao University, Qingdao, Shandong, China
1 shared publication- Heng-Chen Yao
Department of Cardiology Liaocheng People's Hospital Affiliated to Shandong First Medical University Liaocheng Shandong People's Republic of China
1 shared publication Jing-Xian Bai
Shandong First Medical University, 250117 Jinan, Shandong, China
1 shared publication- Qian-Feng Han
Department of Cardiology, Liaocheng People's Hospital, 252000 Liaocheng, Shandong, China
1 shared publication - Yan Zhang1 shared publication
Latest Publications
- 6 February 2026
- Published by SAGE Publications in Angiology
- Vol. 77 (10) , 1340-1341
Letter: Deep Learning Model Significantly Improves MAGGIC Score for Predicting Contrast-Induced Nephropathy in STEMI Patients
- 6 February 2026
- Published by SAGE Publications in Angiology
- Vol. 77 (10) , 1340-1341
Letter: Deep Learning Model Significantly Improves MAGGIC Score for Predicting Contrast-Induced Nephropathy in STEMI Patients
- 22 January 2026
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 40 (4) , 1239-1240
Ultra-Early Efficacy and Hemodynamic Safety: Re-Evaluating the Magnesium Paradox
- 22 January 2026
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 40 (4) , 1239-1240
Ultra-Early Efficacy and Hemodynamic Safety: Re-Evaluating the Magnesium Paradox
- Open Access
- 19 January 2026
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 27 (1)
Three-Dimensional Perspectives on Inflammatory Regulation in Coronary Atherosclerosis: Integrated Mechanisms of Endothelial Priming, Lipid Metabolism, and Cytokine Synergy
Atherosclerosis, a leading cause of global mortality, is a chronic inflammatory disease driven by a vicious cycle of endothelial dysfunction, dysregulated lipid metabolism, and persistent inflammation. This review examines the mechanisms through which diverse triggers initiate the cycle. We discuss key cellular and molecular events, such as the detrimental phenotypic switching of vascular smooth muscle cells. We also describe the processes through which various upstream signals converge on core inflammatory hubs, such as the Toll-like receptor 4 (TLR4)/nuclear factor-κB (NF-κB) pathway and the nucleotide-binding oligomerization domain, leucine-rich repeat-containing family, pyrin domain-containing-3 (NLRP3) inflammasome. By integrating these established mechanisms with recent findings on novel regulators, including the chemokine hemofiltrate CC chemokine 1 (HCC-1) and cell surface glycoRNA, this review identifies several potential new biomarkers. Overall, this review aimed to provide a comprehensive understanding of the pathogenesis of atherosclerosis, informing future research and the development of targeted interventions.
- 19 January 2026
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 27 (1)
Open AccessThree-Dimensional Perspectives on Inflammatory Regulation in Coronary Atherosclerosis: Integrated Mechanisms of Endothelial Priming, Lipid Metabolism, and Cytokine Synergy
Atherosclerosis, a leading cause of global mortality, is a chronic inflammatory disease driven by a vicious cycle of endothelial dysfunction, dysregulated lipid metabolism, and persistent inflammation. This review examines the mechanisms through which diverse triggers initiate the cycle. We discuss key cellular and molecular events, such as the detrimental phenotypic switching of vascular smooth muscle cells. We also describe the processes through which various upstream signals converge on core inflammatory hubs, such as the Toll-like receptor 4 (TLR4)/nuclear factor-κB (NF-κB) pathway and the nucleotide-binding oligomerization domain, leucine-rich repeat-containing family, pyrin domain-containing-3 (NLRP3) inflammasome. By integrating these established mechanisms with recent findings on novel regulators, including the chemokine hemofiltrate CC chemokine 1 (HCC-1) and cell surface glycoRNA, this review identifies several potential new biomarkers. Overall, this review aimed to provide a comprehensive understanding of the pathogenesis of atherosclerosis, informing future research and the development of targeted interventions.
- 28 December 2024
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 39 (6) , 1237-1238
The Relationship Between Lansoprazole and Coronary Heart Disease Risk: Controversial Protective Effects and Cardiovascular Adverse Events
- 28 December 2024
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 39 (6) , 1237-1238
The Relationship Between Lansoprazole and Coronary Heart Disease Risk: Controversial Protective Effects and Cardiovascular Adverse Events